The ATAC Research Fund and Kirsten's Legacy is located at the Translational Genomics Research Institute (TGen) in Phoenix, Arizona. TGen is currently leading the most comprehensive Genomics adrenal cancer study to date and the ATAC Research project is now one of the leaders in adrenal cancer research worldwide. TGen is one of the few facilities in the world that houses such a vast array of technologies and to this date has the largest biomedical super computer anywhere. Many of these technologies have never before used on ACC research and in some cases never used on any other cancer research. TGen has and will continue to discover groundbreaking technologies and hopeful new targets, producing more Adrenocortical Carcinoma (ACC) data than ever before.
THANK YOU FOR YOUR SUPPORT
No current ACC specific trial, however, please call Joyce Schaffer at 480-323-1339 to inquire about other trials that may be helpful in treating your ACC.
Voluntary Patient Survey
The Adrenocortical Cancer Patient Survey has been set up because many ACC survivors and their families have requested more information on what fellow ACC survivors are experiencing. The information you enter will be collected and shared with others taking the survey, in order to help them better deal with this rare disease. The information in the survey will also help inform future research efforts for ACC. The survey is detailed and includes questions relating to personal information like health history, but the results will be anonymous. AT NO TIME WILL YOU BE ASKED TO PROVIDE YOUR NAME, IDENTIFYING INFORMATION or CONTACT INFORMATION. Reports available to you and researchers will include only summaries of the data collected and no individual surveys will be available.